The agreement, which still has to be approved by a U.S. district court in Montana, would see Canada Drugs and two subsidiaries plead guilty, pay a $ 5 million US fine and forfeit $ 29 million US.
Tentative plea deal reached for Winnipeg-based pharmacy accused of selling counterfeit cancer drugs
